Lumira Ventures
Lu Han 韩路, PhD, is a highly experienced professional in the biotechnology and investment sectors, currently serving as a Partner at Lumira Ventures since 2014, with prior roles including Principal and Director of Business Development for Asia Pacific. In addition to the ongoing investments in early-stage companies through the Angelini Lumira Biosciences Fund, Lu Han is involved as an Investor with several companies, including Alpha-9 Oncology, Axonis Therapeutics, Cadence Neuroscience, and GenEp. Notable positions held also include Board Observer for Nocion Therapeutics, Thryv Therapeutics, and Iterion Therapeutics, and Board Member at Deka Biosciences. Educational credentials encompass a PhD in Neuroscience from the University of Toronto, a Bachelor's in Medical Sciences from Western University, and training in management from the Rotman School of Management.
This person is not in any teams
This person is not in any offices
Lumira Ventures
Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer, and more productive lives.